PNC FINANCIAL SERVICES GROUP, INC.
Position in PRME — Prime Medicine, Inc.
CIK 713676
Pittsburgh, PA
Position in PRME
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$1,177
+$67 QoQ
Shares Held
319
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#171
of 186 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PRME Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PNC FINANCIAL SERVICES GROUP, INC. holds $113,274,406 across 262 Biotechnology names. PRME ranks #224 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
69,358 | $34,452,195 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
16,662 | $10,389,420 | |
| 3 | TECH |
BIO-TECHNE Corp
|
77,074 | $5,445,277 | |
| 4 | MRNA |
Moderna, Inc.
|
70,829 | $4,960,151 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
89,646 | $4,925,149 | |
| 6 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
39,473 | $3,847,827 | |
| 7 | INCY |
Incyte Corp
|
32,777 | $3,715,597 | |
| 8 | ARGX |
Argenx SE
|
3,967 | $3,680,460 |
All Filings in PRME
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,177 | 319 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $1,110 | 319 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $1,106 | 319 | Shares | Defined | 2026-02-06 | |
| 2025-09-30 | $1,767 | 319 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $787 | 319 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $644 | 324 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $426 | 146 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $108 | 28 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $585 | 114 | Shares | Defined | 2024-08-09 | |
| No filing history on record for this holder in this stock. | ||||||